Physician density and hospitalization for inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 17, Issue 2, 2011, Pages 633-638

  Ananthakrishnan, Ashwin N ^a   McGinley, Emily L ^a   Binion, David G ^b   Saeian, Kia ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

complications; Crohn's disease; hospitalization; IBD; inflammatory bowel disease; physician density; ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; EMERGENCY WARD; ENTERITIS; FEMALE; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; HYPOVOLEMIA; LENGTH OF STAY; MALE; MALNUTRITION; OUTCOME ASSESSMENT; PATIENT CODING; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; UNITED STATES;

ADULT; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PHYSICIANS; RISK FACTORS; SURVIVAL RATE;

EID: 78651326019     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21357     Document Type: Article

References (33)

1. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429.
2. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007; 13: 481-489.
3. Leijonmarck CE, Persson PG, Hellers G,. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990; 31: 329-333.
4. Feagan BG, Panaccione R, Sandborn WJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology. 2008; 135: 1493-1499.
5. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005; 128: 862-869.
6. Lichtenstein GR, Yan S, Bala M, et al. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004; 99: 91-96.
7. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn's disease. Inflamm Bowel Dis. 2008; 14: 949-954.
8. Liu JJ,. Health professional shortage and health status and health care access. J Health Care Poor Underserved. 2007; 18: 590-598.
9. Mitka M,. Looming shortage of physicians raises concerns about access to care. JAMA. 14 2007; 297: 1045-1046.
10. Perrin JM, Valvona J,. Does increased physician supply affect quality of care? Health Aff (Millwood). 1986; 5: 63-72.
11. Uhlenhake E, Brodell R, Mostow E,. The dermatology work force: a focus on urban versus rural wait times. J Am Acad Dermatol. 2009; 61: 17-22.
12. Roetzheim RG, Gonzalez EC, Ramirez A, et al. Primary care physician supply and colorectal cancer. J Fam Pract. 2001; 50: 1027-1031.
13. Roetzheim RG, Pal N, Gonzalez EC, et al. The effects of physician supply on the early detection of colorectal cancer. J Fam Pract. 1999; 48: 850-858.
14. Ferrante JM, Gonzalez EC, Pal N, et al. Effects of physician supply on early detection of breast cancer. J Am Board Fam Pract. 2000; 13: 408-414.
15. Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000; 43 (2 Pt 1): 211-218.
16. Sloan FA, Schwartz WB,. More doctors: what will they cost? Physician income as supply expands. JAMA. 1983; 249: 766-769.
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
18. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619.
19. Ananthakrishnan AN, McGinley EL, Binion DG,. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008; 103: 2789-2798.
20. Ananthakrishnan AN, McGinley EL, Binion DG,. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009; 15: 182-189.
21. Ananthakrishnan AN, McGinley EL, Saeian K, et al. Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994-2005. Am J Gastroenterol. 2010; 105: 363-370.
22. Nguyen GC, Bayless TM, Powe NR, et al. Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection. Inflamm Bowel Dis. 2007; 13: 1408-1416.
23. Nguyen GC, Laveist TA, Gearhart S, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol. 2006; 4: 1507-1513.
24. Nguyen GC, Laveist TA, Brant SR,. The utilization of parenteral nutrition during the in-patient management of inflammatory bowel disease in the United States: a national survey. Aliment Pharmacol Ther. 2007; 26: 1499-1507.
25. Boyle BM, Palmer L, Kappelman MD,. Quality of health care in the United States: implications for pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009; 49: 272-282.
26. Kappelman MD, Palmer L, Boyle BM, et al. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010; 16: 125-133.
27. Esrailian E, Spiegel BM, Targownik LE, et al. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther. 2007; 26: 1005-1018.
28. Kappelman MD, Bousvaros A, Hyams J, et al. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007; 13: 890-895.
29. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008; 134: 680-687.
30. Nguyen GC, Steinhart AH,. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis. 2008; 14: 1688-1694.
31. Rejler M, Spangeus A, Tholstrup J, Andersson-Gare B,. Improved population-based care: Implementing patient-and demand-directed care for inflammatory bowel disease and evaluating the redesign with a population-based registry. Qual Manag Health Care. 2007; 16: 38-50.
32. Castro HK, Cross RK, Finkelstein J,. Using a home automated telemanagement (HAT) system: experiences and perceptions of patients with inflammatory bowel disease. AMIA Annu Symp Proc. 2006: 872.
33. Cross RK, Finkelstein J,. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci. 2007; 52: 357-364.